Targeting T and B Lymphocytes in Inflammatory Bowel Diseases: Lessons from Clinical Trials

医学 免疫学 炎症性肠病 T细胞 溃疡性结肠炎 炎症 美罗华 抗体 免疫系统 疾病 内科学
作者
Romana R. Gerner,Alexander R. Moschen,Herbert Tilg
出处
期刊:Digestive Diseases [Karger Publishers]
卷期号:31 (3-4): 328-335 被引量:20
标识
DOI:10.1159/000354687
摘要

Both innate and adaptive immunity play an important role in the pathogenesis of inflammatory bowel diseases (IBDs). There is strong evidence that especially activated T cells initiate and perpetuate inflammation and tissue destruction. The increased numbers of CD4<sup>+</sup> T cells in the intestinal wall of IBD patients may be explained by enhanced influx/activation and decreased apoptosis of these cells. Several studies have demonstrated that the gut-homing receptors CCR9 and α4β7 are selectively induced on T cells during their priming in intestinal inflamed sites. Whereas targeting of activated CD4<sup>+</sup> T cells by specific antibody strategies or neutralization of key T-cell cytokines such as IL-2 or IFN-&#947; has not been effective in human IBD, blocking migration of activated leukocytes, e.g. T cells into the inflamed tissue by specific antibodies such as vedolizumab, seems highly effective. Recently it could also been demonstrated that administration of antigen-specific regulatory T cells to patients with refractory Crohn's disease was not only well tolerated but showed promising results. The role of B cells in human IBD is less clear. B-cell depletion has so far only been studied in ulcerative colitis where rituximab (anti-CD20) therapy failed. Therefore, although the therapeutic targeting of ‘inflammatory' T and B cells was not successful in IBD, especially T cells remain key players in IBD. Targeting either T-cell migration or the use of regulatory T cells appears as the most promising ‘T-cell-directed' therapies in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
周舟完成签到 ,获得积分10
2秒前
V_I_G完成签到 ,获得积分10
3秒前
nick完成签到,获得积分10
4秒前
高高高完成签到 ,获得积分10
7秒前
彪壮的亦瑶完成签到 ,获得积分10
8秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
Perry应助科研通管家采纳,获得60
10秒前
Akim应助科研通管家采纳,获得10
10秒前
鱼雷完成签到,获得积分10
11秒前
廿伊发布了新的文献求助10
13秒前
我是125完成签到,获得积分10
15秒前
依人如梦完成签到 ,获得积分10
16秒前
17秒前
PDIF-CN2完成签到,获得积分10
21秒前
雪雪完成签到 ,获得积分10
22秒前
23秒前
Willow完成签到,获得积分10
26秒前
研研研完成签到,获得积分10
27秒前
大橙子发布了新的文献求助10
29秒前
dejiangcj完成签到 ,获得积分10
30秒前
无味完成签到,获得积分10
31秒前
大气的尔蓝完成签到,获得积分10
32秒前
科研通AI5应助普鲁卡因采纳,获得10
33秒前
略略略完成签到 ,获得积分10
35秒前
zqlxueli完成签到 ,获得积分10
39秒前
无语的断缘完成签到,获得积分10
41秒前
hdx完成签到 ,获得积分10
42秒前
健壮的涑完成签到 ,获得积分10
43秒前
量子星尘发布了新的文献求助10
47秒前
普鲁卡因发布了新的文献求助10
47秒前
高大绝义完成签到,获得积分10
49秒前
51秒前
黄超超发布了新的文献求助10
52秒前
ZEcholy完成签到 ,获得积分20
52秒前
大橙子发布了新的文献求助10
53秒前
小幸运完成签到,获得积分10
55秒前
淡然一德完成签到,获得积分10
58秒前
咖啡豆完成签到 ,获得积分10
59秒前
1分钟前
龙猫爱看书完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022